Thor Medical ASA (TRMED) — Strategic Asset Allocation Index
Thor Medical ASA (TRMED) has a Strategic Asset Allocation Index of 0.4% as of December 2024. Strategic assets (PP&E of Nkr1.43 Million plus long-term investments of Nkr-) total Nkr1.43 Million, measured against net assets of Nkr337.10 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Thor Medical ASA Strategic Asset Allocation Index (2020–2024)
This chart shows how Thor Medical ASA's Strategic Asset Allocation Index has evolved across 5 annual periods from 2020 to 2024. As of December 2024, the index stands at 0.4%, representing strategic assets of Nkr1.43 Million against net assets of Nkr337.10 Million NOK. Explore cash flow conversion of Thor Medical ASA to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Thor Medical ASA (2020–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Thor Medical ASA from 2020 to 2024, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Thor Medical ASA (TRMED) market capitalisation.
| Year | SAAI | Strategic Assets (NOK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.4% | Nkr1.43 Million | Nkr1.43 Million | Nkr- | Nkr337.10 Million | ▲ +0.1 pp |
| 2023 | 0.4% | Nkr1.01 Million | Nkr1.01 Million | Nkr- | Nkr271.93 Million | ▼ -0.5 pp |
| 2022 | 0.8% | Nkr537.00K | Nkr537.00K | Nkr- | Nkr63.84 Million | ▼ -3.4 pp |
| 2021 | 4.2% | Nkr5.94 Million | Nkr5.94 Million | Nkr- | Nkr140.52 Million | ▲ +1.0 pp |
| 2020 | 3.2% | Nkr5.68 Million | Nkr5.68 Million | Nkr- | Nkr178.67 Million | — |